Insiders Eli Lilly and Company Deutsche Boerse AG

Equities

Market Closed - Deutsche Boerse AG Other stock markets 13:39:57 2024-06-21 EDT			5-day change	1st Jan Change
830.2 ^EUR	+0.61%		+0.89%	+57.68%

06-21	Amylyx to buy bankrupt Eiger's experimental drug to treat low blood sugar	RE
06-21	Weight-loss drug Zepbound resolves sleep apnea in up to 52% of patients, Lilly says	RE

A weight loss ETF	06-18	MT
Alzheon, Inc Announces Appointment of Gino Santini to Board of Directors	06-12	CI
Alphabet Appoints Anat Ashkenazi as CFO	06-05	MT
Eli Lilly's CFO Anat Ashkenazi Resigns	06-05	MT
Eli Lilly CFO Anat Ashkenazi Resigns	06-05	MT
Correction to Alphabet CFO Article	06-05	DJ
Google Poaches Eli Lilly Finance Chief Ashkenazi -- Update	06-05	DJ
Alphabet: Eli Lilly CFO recruited	06-05	CF
Google Poaches Eli Lilly Finance Chief Ashkenazi	06-05	DJ
Eli Lilly Chief Financial Officer Anat Ashkenazi Leaving	06-05	DJ
Alphabet names Eli Lilly executive Anat Ashkenazi as CFO	06-05	RE
Eli Lilly finance chief to leave company	06-05	RE
Eli Lilly and Company Announces Resignation of Anat Ashkenazi as Executive Vice President	06-05	CI
Eli Lilly and Company Announces Resignation of Anat Ashkenazi as Chief Financial Officer, Effective July 2024	06-05	CI
Eli Lilly: recruits Bristol Myers Quality Director	06-04	CF
Eli Lilly Names Melissa Seymour Executive VP of Global Quality	06-04	DJ
Eli Lilly and Company Appoints Melissa Seymour as Executive Vice President of Global Quality and Member of the Executive Committee, Effective July 22, 2024	06-04	CI
Eli Lilly Ethics/Compliance Chief Alonzo Weems to Retire	05-15	DJ
Eli Lilly: Alonzo Weems to retire at the end of the year	05-15	CF
Eli Lilly and Company Announces Retirement of Alonzo Weems, Executive Vice President of Enterprise Risk Management and Chief Ethics and Compliance Officer, Effective December 31, 2024	05-15	CI

No results for this search

David Ricks, CEO of Eli Lilly: A market of over a billion people

March 12, 2024 at 02:47 pm